Spot the next big opportunity — before the crowd.
Live countdowns, subscription status, AI analysis & investor-interest scores for every IPO and NFO in India.
Live data from NSE IndiaThe IPO currently shows extremely weak investor demand with a 0.0x subscription, implying the valuation may not be perceived as attractive by investors. This low initial interest suggests it may not be suitable for investors seeking immediate listing gains. Not investment advice.
With a 0.0x subscription, initial demand is extremely low, suggesting the valuation may be unattractive to investors. This IPO currently appears unsuitable for retail investors, especially those seeking listing gains, due to the lack of early interest. Not investment advice.
With a 0.0x subscription, demand for this IPO appears extremely weak, raising concerns about its current valuation appeal to investors. Retail investors should exercise caution given the lack of initial interest. Not investment advice.
The current 0.0x subscription indicates extremely weak demand for the IPO; valuation insights are not available from the provided data. Given the lack of initial interest, it is currently unsuitable for most retail investors. Not investment advice.
Review the RHP and your risk appetite before applying. Not investment advice.
Paras Healthcare is an upcoming mainboard IPO with a significant issue size. Given the lack of subscription data, a neutral stance is prudent until more information is available. Not investment advice.
Review the RHP and your risk appetite before applying. Not investment advice.
Review the RHP and your risk appetite before applying. Not investment advice.